Dr. Michael C. Wehr is currently the leader of the Research Group Cell Signaling, Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany. He is also a faculty member of the international Max Planck Research School for Translational Psychiatry (IMPRS-TP), Munich, Germany. He received his PhD degree in Molecular Biology from Heidelberg University in 2006. He served as a PostDoc researcher at Apoptosis and Proliferation Control Laboratory of London Research Institute (London, UK) from August 2007 to March 2011 and as a Project Leader at the Max Planck Institute of Experimental Medicine from April 2011 to March 2013. Dr. Wehr has been the Chief Technology Officer of Systasy Bioscience GmbH since July 2012 and an Assistant Professor at Ludwig-Maximilians-Universität (LMU) München since August 2020. He is an experienced Chief Technology Officer with a demonstrated history of working in the biotechnology industry and is skilled in Neuroscience, Cancer Research, Drug Discovery, Cell-based assays, and Barcoding Technologies. He has 30 publications with more than 1900 citations (Scopus, 28 April 2024) and an h-index of 15. His main research areas include Psychiatric and Neurological Disorders, Cancer Biology, Cell Signaling, Pharmacology, and Human Disease Models using Stem Cell Technologies.